Review Article
Should We Monitor ScVO2 in Critically Ill Patients?
Table 1
Summary of the studies comparing SvO2 and ScvO2 in humans or in experimental models.
| | Author (year) | Type of patients | Conclusion | Correlation coefficient |
| | Tahvanainen et al. [13] (1982) | Intensive care (42) | ScvO2 = SvO2 | NC | | Wendt et al. [14] (1990) | Intensive care (19) | ScvO2 ~ SvO2 | 0,78 | | Kong et al. [15] (1990) | Kidney failure (8) | ScvO2 ~ SvO2 | NC | | Berridge et al. [16] (1992) | Intensive care (51) | ScvO2 = SvO2 | 0,92 | | Herrera et al. [17] (1993) | Thoracic surgery (23) | ScvO2 = SvO2 | NC | | Pieri et al. [18] (1995) | Major surgery (39) | ScvO2≠ SvO2, nonsubstituable | 0,90 | | Ladakis et al. [19] (2001) | Intensive care (61) | ScvO2 = SvO2 | 0,94 | | Reinhart et al. [11] (2004) | Intensive care (32) | ScvO2 ~ SvO2 | 0,81 | | Chawla et al. [20] (2004) | Intensive care (53) | ScvO2 > SvO2 | 0.88 | | Dueck et al. [21] (2005) | Neurosurgery (70) | ScvO2≠ SvO2, substituable evolution | ≥0,75 | | Ho et al. [22] (2010) | Intensive care | ScVO2≠ SvO2, nonsubstituable | NC |
|
|
